|
|
Bundesamt für Gesundheit. (2012). Die Heroingestützte Behandlung : Behandlung mit Diacetylmorphin (HeGeBe) in den Jahren 2011. Bern: Bundesamt für Gesundheit (BAG), Nationale Präventionsprogramme.
Keywords: treatment and maintenance; heroin-assisted treatment; monitoring; health; communicable disease; statistical data; Switzerland; annual report
|
|
|
|
various. (2011). Im Brennpunkt 1 / 2011 : Zum ersten Mal in Suchtbehandlung : Klienten und Klientinnen in Erstbehandlung : Entwicklung zwischen 2005 und 2009. Bern; Lausanne; Zürich: Act-Info.
Keywords: treatment and maintenance; alcoholism treatment unit; inpatient care; outpatient care; monitoring; statistical data; Switzerland; report
|
|
|
|
Allemann, D., Pauli, H., Mürner, A., Helmlin, H. - J., & Steiner, S. (2010). Substance testing on the dance floor with a mobile high-tech lab (Office of the Cantonal Pharmacist, Ed.). Berne: State of Berne, Health & Social Welfare Department, Office of the Cantonal Pharmacist.
Abstract: Schweiz – Bern. Ergebnisse von 10 Jahren Drugchecking: Das Kantonsapothekeramt in Bern hat mehr als 1700 Substanzenproben an über 100 Events analysiert. Auf einem Poster sind nun die wichtigsten Ergebnisse der letzten 10 Jahre abgebildet. Besonderes Augenmerk ist auf die zwei Diagramme zu den Veränderungen bei XTC-Tabletten und Kokain zu richten. Die Anzahl der als XTC verkauften Tabletten, welche statt dem erwarteten MDMA andere Wirkstoffe enthielten, sank seit 2000 stetig ab, mit einem Knick in den Jahren 2008/2009. Komplementär hierzu stieg die Anzahl von Tabletten mit m-CPP. Bei Kokain ist ein kontinuierlicher Abfall des Reinheitsgrades zu verzeichnen, von durchschnittlich 60% hinunter auf durchschnittlich 30%. A Swiss lab takes a particularly sophisticated approach to examining the contents of drugs in a party context. Includes graphs showing trends in over 1700 samples tested on site by the mobile lab.
Keywords: harm reduction; nightlife; prevention; addiction; AOD dependence; chemical addiction; physical and chemical analysis and measurement; target group; Switzerland; Berne (canton); Berne
|
|
|
|
European Monitoring Centre for Drugs and Drug Addiction. (2010). Problem amphetamine and methamphetamine use in Europe (European Monitoring Centre for Drugs and Drug Addiction, Ed.). Luxembourg: Office for Official Publications of the European Communities.
Abstract: Focusing on European countries where amphetamine or methamphetamine is an important part of the drug problem, this Selected issue looks at the current situation in the light of the historical development of amphetamines use since the introduction of these substances as medicines in the 1930s. The history of amphetamines use is the result of an interplay of global forces, such as the spread of recreational drug use in the 1960s and the arrival of heroin on the European drug scene in the 1970s, and local events such as the rise of small-scale pervitin (methamphetamine) production in what was then Czechoslovakia. The outcome of this is that, in the present day, problem amphetamines use across Europe is marked by strong national characteristics, possibly more so than any other of the major illicit drugs.
Keywords: addiction; AOD use, abuse, and dependence; chemical addiction; amphetamines; methamphetamines; history; drug trafficking; AOD supply; other drug laws; AOD effects and consequences; Europe
|
|
|
|
Rhodes, T., & Hedrich, D. (2010). Harm reduction : evidence, impacts and challenges. Monographs, 10. Luxembourg: Office for Official Publications of the European Communities.
Abstract: The EMCDDA’s 10th scientific monograph, entitled Harm reduction: evidence, impacts and challenges provides a comprehensive overview of the harm reduction field. Part I of the monograph looks back at the emergence of harm reduction approaches and their diffusion, and explores the concept from different perspectives, including international organisations, academic researchers and drug users. Part II is dedicated to current evidence and impacts of harm reduction and illustrates how the concept has broadened to cover a wide range of behaviours and harms. Part III addresses the current challenges and innovations in the field. The core audience of the monograph comprises policymakers, healthcare professionals working with drug users, as well as the wider interested public.
Keywords: harm reduction; history; cooperation; research; drug user; public policy on illicit drugs; international area; Europe
|
|
|
|
European Monitoring Centre for Drugs and Drug Addiction, & Europol. (2010). Cocaine : a European Union perspective in the global context. Luxembourg: Publications Office of the European Union.
Abstract: This report provides an overview of what is known about how cocaine is produced and trafficked into the European Union. It aims to provide a better understanding of the actors involved, the routes taken, and the scale of the problem in Europe. It also reviews some of the supply reduction responses already developed at European level. Its findings are based on the latest data and analysis available from specialised European and international organisations, NGOs and scholars. This publication is structured in a way that provides a condensed review of key issues relevant to understanding how cocaine reaches European markets. Background information on the chemistry and legal status of cocaine and crack cocaine, as well as key European figures, are also provided.
Keywords: addiction; AOD dependence; chemical addiction; cocaine; crack cocaine; illegal production of drugs; drug trafficking; drug market; international area; Europe
|
|
|
|
European Monitoring Centre for Drugs and Drug Addiction, & Europol. (2010). EMCDDA-Europol 2009 annual report on the implementation of council decision 2005/387/JHA : in accordance with article 10 of council decision 2005/387/JHA on the information exchange, risk-assessment and control of new psychoactive substances. Implementation reports. Lisbon; The Hague: European Monitoring Centre for Drugs and Drug Addiction (EMCDDA); Europol.
Keywords: cooperation; risk assessment; monitoring; internet; addiction; chemical addiction; AOD dependence; other AOD substances; mephedrone; spice; designer drug; research chemical; cocaine contaminant; opioid contaminant; Europe; annual report
|
|
|
|
Allemann, D., Pauli, H., Mürner, A., Helmlin, H. - J., & Steiner, S. (2010). Substance testing on the dance floor with a mobile high-tech lab (Office of the Cantonal Pharmacist, Ed.). Berne: State of Berne, Health & Social Welfare Department, Office of the Cantonal Pharmacist.
Abstract: A Swiss lab takes a particularly sophisticated approach to examining the contents of drugs in a party context. Includes graphs showing trends in over 1700 samples tested on site by the mobile lab.
Keywords: harm reduction; nightlife; prevention; addiction; AOD dependence; chemical addiction; physical and chemical analysis and measurement; target group; Switzerland; Berne (canton); Berne
|
|
|
|
Office of National Drug Control Policy. (2012). The 2012 national drug control srategy : bilding on a record of reform : executive summary (Office of National Drug Control Policy, Ed.). Washington: Executive Office of the President of the United States.
Keywords: prevention; treatment and maintenance; law enforcement; government and politics; AOD public policy strategy; public policy on AOD; public policy on illicit drugs; addiction; AOD use, abuse, and dependence; AODR crime; drug dealing; drug trafficking; illegal production of drugs; illicit drug industry; drug market; prevention through education; adolescent; cooperation; United States; international area
|
|
|
|
Office of National Drug Control Policy. (2011). 2011 national drug control strategy : executive summary (Office of National Drug Control Policy, Ed.). Washington: Executive Office of the President of the United States.
Keywords: prevention; treatment and maintenance; law enforcement; government and politics; AOD public policy strategy; public policy on AOD; public policy on illicit drugs; addiction; AOD use, abuse, and dependence; AODR crime; drug dealing; drug trafficking; illegal production of drugs; illicit drug industry; drug market; prevention through education; adolescent; cooperation; United States; international area
|
|
